Company Filing History:
2 out of 2 
1 out of 1,997 
Years Active: 2014-2023
Title: Fubao Lin: Innovator in Wound Healing Technologies
Introduction
Fubao Lin is a notable inventor based in Stony Brook, NY (US), recognized for his contributions to the field of wound healing. He holds a total of 3 patents that focus on innovative treatments aimed at enhancing recovery from injuries.
Latest Patents
One of his latest patents involves peptides derived from fibronectin that exhibit improved bioactivity and reduced susceptibility to neutrophil elastase degradation. These polypeptides are designed to be neutrophil elastase-resistant and can effectively bind to growth factors, thereby enhancing their activity. This innovation is particularly useful for improving wound healing in patients. Another significant patent details methods for treating burns with intravenous cP12 within a critical window of 2 to 6 hours post-injury. This research has shown that delaying treatment with fibronectin-derived peptides, such as cP12, for about 4 hours after wounding yields superior wound-closing results compared to treatments administered at 1 hour or after 8 hours.
Career Highlights
Fubao Lin has worked with various organizations, including Neomatrix Therapeutics Inc. and the State University of New York. His work has significantly impacted the development of advanced therapeutic strategies for wound management.
Collaborations
Throughout his career, Fubao Lin has collaborated with notable individuals such as Richard August Clark and Richard A Clark. These partnerships have contributed to the advancement of his research and innovations.
Conclusion
Fubao Lin's work in the field of wound healing exemplifies the importance of innovation in medical treatments. His patents reflect a commitment to improving patient outcomes through advanced therapeutic methods.